The investigators were as listed in Charache et al (1995). 
| INTRODUC TI ON
Therapy of patients with sickle-cell anemia (SCA) with hydroxyurea (HU) improves their clinical and hematological characteristics. [1] [2] [3] [4] [5] In the randomized, double-blind, placebo-controlled study of hydroxyurea in sickle-cell anemia (MSH), HU had a salutary effect on the clinical course of the disease in adults with three or more painful crises per year. 3 Hematological effects of HU included increased Hb F synthesis, Hb levels, mean corpuscular volume (MCV), proportion of F cells, and red blood cell (RBC) hydration status. [1] [2] [3] [4] White blood cell (WBC), platelet, reticulocyte, and dense-cell counts were reduced in the patients who received HU. 3 The purpose of this study was to determine the effects of HU, fetal hemoglobin (Hb F), and α-thalassemia on the rheological properties of sickle RBC of patients with SCA. Improvement in RBC rheology after treatment with HU was described previously in two patients treated with HU 1 and more
recently in an open-label, uncontrolled study from a single institution involving about 30 patients. 6, 7 In this study, we investigated the modulating role of HbF and α-thalassemia on RBC deformability in patients with and without HU, with some patients enrolled in MSH.
| PATIENTS AND ME THODS

| Patients
Adult patients with SCA were enrolled in the Sickle Cell Program of the Cardeza Foundation of Thomas Jefferson University and were followed up prospectively from 1992 to 1995, the period during which the MSH study was conducted. All patients were adult African
Americans. Hematologic and rheological data were performed when the patients were in their usual asymptomatic steady state in the outpatient clinic. Definitions of steady state were as described previously. 8 The study was approved by the IRB, and written consent was obtained from all patients. The distribution of the patients stud- was used for the measurement of RBC deformability only. 
| Hematological data
| Measurement of RBC deformability
The ektacytometer, a viscodiffractometer, designed and previously described by Bessis and Mohandas, 11, 12 was used to measure whole cell deformability in room air as a continuous function of the suspending medium osmolality at a constant applied shear stress of TA B L E 1 Effects of HU on hematological parameters 170 dynes/cm 2 (osmotic gradient ektacytometry). For these studies, the deformability index (DI) of RBC was continuously recorded as the suspending medium osmolality was increased from 50 to 500 mosmol/kg as previously described. 1 The DI values at 290 mosmol/kg were used for further analyses.
| Determination of a-globin genotypes
α-Globin genotypes were determined by Southern blot hybridization 13 of genomic DNA extracted from peripheral blood leukocytes.
The restriction endonucleases used were Bam HI and Bgl 11, and the probe was Bam H 1 -linearized α-cDNA JW 10 1 plasmid 14 , which was labeled with 32 P by nick translation. were reported as mean ± SD (minimum-maximum value).
| Statistical methods
| RE SULTS
| DI and HU
Hematological values of the patients studied are reported in had 2 α-genes deleted and, although the mean value of this subgroup was close to the mean value of patients with only one α-gene deleted, the sample size was considered to be too small to analyze this subgroup separately. In order to determine whether the effects of Hb F and α-thalassemia on RBC deformability were independent of each other or not, we arbitrarily divided the patients into two groups: those with Hb F >10% and those with Hb F <10% (Figure 4 ), as was previously described. 15 Our results demonstrated that SCA patients without α-thalassemia and HbF <10% had lower DI than patients with α-thalassemia and HbF <10% and patients with or without α-thalassemia but with HbF >10%. Finally, DI measured in patients without α-thalassemia and HbF >10% was higher than in the three other subgroups. The multivariate analysis including both raw values of HbF and the alpha-thalassemic status (ie, the presence or not), demonstrated an independent association of these two biological parameters (P < 0.001 and P < 0.05 for HbF and alpha-thalassemia, respectively) with DI.
| DI, Hb F and α-thalassemia
F I G U R E 1 Effects of Hydroyurea (HU) on RBC deformability measured at 290 mmosmol/L (DI 290). SCA without HU group: n = 91; SCA with HU group: n = 21; SCA with placebo group: n = 9; Control group: n = 113. Different from the SCA with HU group: **P < 0.01; ***P < 0.001. Different from the three SCA groups: ### P < 0.001
| D ISCUSS I ON
The clinical manifestations of sickle-cell disease vary latitudinally among patients and longitudinally in the same patient over time. Some patients with SCA have mild disease, whereas others suffer from a severe form and die at a relatively young age. Age, α-thalassemia, Hb F level, iron overload, milder anemia, lower lactate dehydrogenase level, and higher tricuspid regurgitation velocity were associated with greater frequency of severe VOCs. [16] [17] [18] In addition, the rheology of sickle blood plays an important role in the pathogenesis of vaso-occlusion. [19] [20] [21] The rheology of blood, in 
Effects of α-thalassemia on RBC deformability measured at 290 mmosmol/L (DI 290) after excluding those under HU therapy. Alpha-thalassemic group: n = 31; No alpha-thalassemia group: n = 60. Difference between groups: *P < 0.05
Effects of α-thalassemia and HbF level on RBC deformability measured at 290 mmosmol/L (DI 290) after excluding those under HU therapy. SCA patients with alpha-thalassemia and HbF <10%: n = 23; SCA patients without alpha-thalassemia and HbF <10%: n = 48; SCA patients with alpha-thalassemia and HbF>10%: n = 8; SCA patients without alpha-thalassemia and HbF>10%: n = 12. ### Different from the three other groups (P < 0.001); *Different from the three other groups (P < 0.001) improved the rheological characteristics of sickle RBCs as shown in this study and others. 6, 7 However, there are patients with very low Hb F levels (<2%) and mild disease and patients with high Hb F levels (>20%) and severe disease. In addition, at least 25% of patients do not respond to HU therapy. The incidence of noncompliance and lack of response to hydroxyurea are not well studied and vary among institutions. Moreover, the definition of response depends on HbF level, MCV, leukocyte count, frequency of VOCs, etc. 18 The correlation between DI and HbF was moderate (r = 0.51 with all subjects and r = 0.34 excluding those on hydroxyurea), which indicates that HbF level is not the only determinant of RBC deformability in SCA.
Other factor to the decreased hemolytic rate observed in these individuals.
| CON CLUS ION
This study shows that elevated levels of Hb F with or without HU and α-thalassemia improve the rheology of sickle RBCs which, in turn, improve the clinical picture of SCA. The limitation of the study is the small number of patients with α-thalassemia. 
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